UK charity donates generous funding for eye disease treatment

Article

Fight for Sight has donated £1.6 million towards ten research grants focused on tackling sight loss and eye disease treatment.

Fight for Sight has donated £1.6 million towards ten research grants focused on tackling sight loss and eye disease treatment.

The research grants will be given to a clinical fellowship, two early career investigator awards and seven project grants. Work will begin universities and hospitals across the UK and aims to develop treatment for age-related macular degeneration, glaucoma, eyelid cancer, inherited paediatric retinal disease and diabetic retinopathy.

Dr Dolores Conroy, Director of Research at Fight for Sight, commented, "Currently, there are a huge number of eye conditions that we do not know enough about, and which have few treatment options – such as age-related macular degeneration and diabetic retinopathy. It is therefore crucial that we invest as much as we can into research, which could bring us closer to finding new ways to help people living with sight loss. We hope our commitment to funding pioneering research will bring us even closer to a future everyone can see.”

To find out more about the charity please click here

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.